News

VentureBeat5mon
Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare ... - VentureBeat
Jarret Glasscock, founder and CEO, transitions to Chief Technology Officer (CTO), Board Member, and President ST. LOUIS–(BUSINESS WIRE)–January 8, 2025– Cofactor Genomics, Inc., a commercial ...
Morningstar3mon
Clutch and Care Continuity Announce Strategic Partnership to Revolutionize Patient Engagement and Care Coordination in Healthcare - Morningstar
AMBLER, PENNSYLVANIA / ACCESS Newswire / March 3, 2025 / Clutch, an AI-driven Retention & Loyalty Platform, and Care Continuity, a leader in Patient Navigation and Care Coordination solutions ...
Healio11y
The cash flow benefits of continuity of care part 3 - Healio
Picking up where we left off last time regarding recall and continuity of care, let ... . Pull 20 charts at random, per doctor, of patients last seen 2 to 3 years ago (but not in the ...
Business Wire5mon
Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Approved ...
Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, ...